What a difference three months make! At the end of last year, with an improving global economy underpinning positive earnings revisions, equity markets looked poised for more upside. Something ended up rattling the goldilocks scenario, though.
Three months ago, we already pointed out that “nothing ever moves in a straight line”. Call it sixth sense, call it being in the markets for more years than we care to count, this time it was President Trump deciding to wage a trade war that threw a spanner in the works. Or at least he is making concrete threats to do so, possibly with the goal to strike a ‘good deal’ for America.
As economists, we can wonder how good that deal will be for the US consumer or the many US corporates that rely on imported goods. We can see domestic inflationary pressures coming, should the protectionist measures escalate. As investors, we have to decide how to allocate assets in these markets. Our advice is to keep your eye on the prize. Rather than looking at short-term volatility, we should stay focused on the underlying macro dynamics.
The global economic cycle is still improving, and central banks, including the Fed, are moving in cautious and well flagged steps. If this continues, which is the base case of our fundamental equities investment teams, we should use the dips as a buy opportunity. Yet, we need to continue to monitor the risks. Until now, President Trump’s trade tariffs have made more noise than actual economic impact.
Given the number of exemptions already granted — Canada and Mexico on a long-term basis, plus Australia, Argentina, the EU, and South Korea at least temporarily — it looks like these tariffs were more of a negotiating tactic than they initially seemed, and that China is the key target. The measures per se have a limited impact on Chinese GDP, which the Chinese government could offset by implementing some form of stimulus. President Trump is also proposing measures to limit China’s investments in ‘sensitive technologies’. This de facto was already the status quo given the strict oversight by CFIUS, the US government body that reviews foreign investments in the country.
While the current status of tariffs is limited, the key question to ask is how big the risk of escalation is, with maybe more US measures, and significant retaliation from China. Thus far, the Chinese government is responding in a firm but measured way. It has announced tariffs on USD 50 billion in US products, contingent on when the US will actually implement its tariffs on Chinese products. It also appears that Beijing and Washington are currently in talks, taking advantage of the 60-day period before the Section 301-based tariffs take effect. We would expect some concessions to be made and the situation to diffuse, not without the occasional tweet.
That said, we have to be mindful of the risks, and should all negotiations fail, and a full-fledged trading war break out, equity markets would face the proverbial double whammy. On the one end, earnings might be hit as both exporters and importers, depending on what side of the trade tariffs they sit, suffer. On the other end, we could expect inflationary pressures to ramp up in the US, prompting the Fed to hike rates not in line with the improvement in economic growth (as it has done thus far) but to stem inflation.
A gradual tightening cycle that responds to improvements in the global economy has historically been positive for equity markets, but a steeper tightening path to stem inflationary pressures is likely to have a negative impact. As we said, the latter is not our base case. President Trump likes to rattle his adversaries to make a deal, and China is coming to the table.
While the world is focused on potential trade wars, we see some other elements that need monitoring. Although we are still positive on developed equity markets, we are concerned about volatility over the coming quarter, upcoming protectionism and the risk of further inflationary pressures if the US economy overheats. We are more upbeat about emerging equity markets. Although, here too, trade protectionism and potential inflationary pressure weigh on our optimism, the global economic environment is still supportive for emerging markets, with solid growth across developed and emerging countries and inflation still at a low level.
The Robeco Capital Growth Funds have not been registered under the United States Investment Company Act of 1940, as amended, nor or the United States Securities Act of 1933, as amended. None of the shares may be offered or sold, directly or indirectly in the United States or to any U.S. Person (within the meaning of Regulation S promulgated under the Securities Act of 1933, as amended (the “Securities Act”)). Furthermore, Robeco Institutional Asset Management B.V. (Robeco) does not provide investment advisory services, or hold itself out as providing investment advisory services, in the United States or to any U.S. Person (within the meaning of Regulation S promulgated under the Securities Act).
This website is intended for use only by non-U.S. Persons outside of the United States (within the meaning of Regulation S promulgated under the Securities Act who are professional investors, or professional fiduciaries representing such non-U.S. Person investors. By clicking “I Agree” on our website disclaimer and accessing the information on this website, including any subdomain thereof, you are certifying and agreeing to the following: (i) you have read, understood and agree to this disclaimer, (ii) you have informed yourself of any applicable legal restrictions and represent that by accessing the information contained on this website, you are not in violation of, and will not be causing Robeco or any of its affiliated entities or issuers to violate, any applicable laws and, as a result, you are legally authorized to access such information on behalf of yourself and any underlying investment advisory client, (iii) you understand and acknowledge that certain information presented herein relates to securities that have not been registered under the Securities Act, and may be offered or sold only outside the United States and only to, or for the account or benefit of, non-U.S. Persons (within the meaning of Regulation S under the Securities Act), (iv) you are, or are a discretionary investment adviser representing, a non-U.S. Person (within the meaning of Regulation S under the Securities Act) located outside of the United States and (v) you are, or are a discretionary investment adviser representing, a professional non-retail investor. Access to this website has been limited so that it shall not constitute directed selling efforts (as defined in Regulation S under the Securities Act) in the United States and so that it shall not be deemed to constitute Robeco holding itself out generally to the public in the U.S. as an investment adviser. Nothing contained herein constitutes an offer to sell securities or solicitation of an offer to purchase any securities in any jurisdiction. We reserve the right to deny access to any visitor, including, but not limited to, those visitors with IP addresses residing in the United States.
This website has been carefully prepared by Robeco. The information contained in this publication is based upon sources of information believed to be reliable. Robeco is not answerable for the accuracy or completeness of the facts, opinions, expectations and results referred to therein. Whilst every care has been taken in the preparation of this website, we do not accept any responsibility for damage of any kind resulting from incorrect or incomplete information. This website is subject to change without notice. The value of the investments may fluctuate. Past performance is no guarantee of future results. If the currency in which the past performance is displayed differs from the currency of the country in which you reside, then you should be aware that due to exchange rate fluctuations the performance shown may increase or decrease if converted into your local currency. For investment professional use only. Not for use by the general public.